ID   VP37A_HUMAN             Reviewed;         397 AA.
AC   Q8NEZ2; Q336D5; Q6NW27; Q8N3D7; Q8TBL7; Q96DL9;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   07-APR-2021, entry version 155.
DE   RecName: Full=Vacuolar protein sorting-associated protein 37A;
DE            Short=hVps37A;
DE   AltName: Full=ESCRT-I complex subunit VPS37A;
DE   AltName: Full=Hepatocellular carcinoma-related protein 1;
GN   Name=VPS37A; Synonyms=HCRP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=14623289; DOI=10.1016/j.bbrc.2003.10.109;
RA   Xu Z., Liang L., Wang H., Li T., Zhao M.;
RT   "HCRP1, a novel gene that is downregulated in hepatocellular carcinoma,
RT   encodes a growth-inhibitory protein.";
RL   Biochem. Biophys. Res. Commun. 311:1057-1066(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH TSG101.
RX   PubMed=15218037; DOI=10.1074/jbc.m405226200;
RA   Stuchell M.D., Garrus J.E., Mueller B., Stray K.M., Ghaffarian S.,
RA   McKinnon R., Kraeusslich H.-G., Morham S.G., Sundquist W.I.;
RT   "The human endosomal sorting complex required for transport (ESCRT-I) and
RT   its role in HIV-1 budding.";
RL   J. Biol. Chem. 279:36059-36071(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TSG101; VPS28 AND HGS.
RX   PubMed=15240819; DOI=10.1091/mbc.e04-03-0250;
RA   Bache K.G., Slagsvold T., Cabezas A., Rosendal K.R., Raiborg C.,
RA   Stenmark H.;
RT   "The growth-regulatory protein HCRP1/hVps37A is a subunit of mammalian
RT   ESCRT-I and mediates receptor down-regulation.";
RL   Mol. Biol. Cell 15:4337-4346(2004).
RN   [7]
RP   INTERACTION WITH TSG101, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18005716; DOI=10.1016/j.chom.2007.06.003;
RA   Morita E., Sandrin V., Alam S.L., Eckert D.M., Gygi S.P., Sundquist W.I.;
RT   "Identification of human MVB12 proteins as ESCRT-I subunits that function
RT   in HIV budding.";
RL   Cell Host Microbe 2:41-53(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION IN AN ESCRT-I COMPLEX WITH UBAP1, AND SUBUNIT.
RX   PubMed=21757351; DOI=10.1016/j.cub.2011.06.028;
RA   Stefani F., Zhang L., Taylor S., Donovan J., Rollinson S., Doyotte A.,
RA   Brownhill K., Bennion J., Pickering-Brown S., Woodman P.;
RT   "UBAP1 is a component of an endosome-specific ESCRT-I complex that is
RT   essential for MVB sorting.";
RL   Curr. Biol. 21:1245-1250(2011).
RN   [12]
RP   TISSUE SPECIFICITY, VARIANT SPG53 ASN-382, AND CHARACTERIZATION OF VARIANT
RP   SPG53 ASN-382.
RX   PubMed=22717650; DOI=10.1136/jmedgenet-2012-100742;
RA   Zivony-Elboum Y., Westbroek W., Kfir N., Savitzki D., Shoval Y., Bloom A.,
RA   Rod R., Khayat M., Gross B., Samri W., Cohen H., Sonkin V., Freidman T.,
RA   Geiger D., Fattal-Valevski A., Anikster Y., Waters A.M., Kleta R.,
RA   Falik-Zaccai T.C.;
RT   "A founder mutation in Vps37A causes autosomal recessive complex hereditary
RT   spastic paraparesis.";
RL   J. Med. Genet. 49:462-472(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Component of the ESCRT-I complex, a regulator of vesicular
CC       trafficking process. Required for the sorting of endocytic
CC       ubiquitinated cargos into multivesicular bodies. May be involved in
CC       cell growth and differentiation. {ECO:0000269|PubMed:15240819}.
CC   -!- SUBUNIT: Component of the ESCRT-I complex (endosomal sorting complex
CC       required for transport I) which consists of TSG101, VPS28, a VPS37
CC       protein (VPS37A to -D) and MVB12A or MVB12B in a 1:1:1:1 stoichiometry.
CC       Interacts with TSG101, VPS28 and HGS. Component of an ESCRT-I complex
CC       (endosomal sorting complex required for transport I) which consists of
CC       TSG101, VPS28, VPS37A and UBAP1 in a 1:1:1:1 stoichiometry.
CC       {ECO:0000269|PubMed:15218037, ECO:0000269|PubMed:15240819,
CC       ECO:0000269|PubMed:18005716, ECO:0000269|PubMed:21757351}.
CC   -!- INTERACTION:
CC       Q8NEZ2; P54252: ATXN3; NbExp=3; IntAct=EBI-2850578, EBI-946046;
CC       Q8NEZ2; G5E9A7: DMWD; NbExp=3; IntAct=EBI-2850578, EBI-10976677;
CC       Q8NEZ2; P22607: FGFR3; NbExp=3; IntAct=EBI-2850578, EBI-348399;
CC       Q8NEZ2; Q8TB36: GDAP1; NbExp=3; IntAct=EBI-2850578, EBI-11110431;
CC       Q8NEZ2; P28799: GRN; NbExp=3; IntAct=EBI-2850578, EBI-747754;
CC       Q8NEZ2; P06396: GSN; NbExp=3; IntAct=EBI-2850578, EBI-351506;
CC       Q8NEZ2; P01112: HRAS; NbExp=3; IntAct=EBI-2850578, EBI-350145;
CC       Q8NEZ2; O43464: HTRA2; NbExp=3; IntAct=EBI-2850578, EBI-517086;
CC       Q8NEZ2; P42858: HTT; NbExp=6; IntAct=EBI-2850578, EBI-466029;
CC       Q8NEZ2; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-2850578, EBI-1055254;
CC       Q8NEZ2; O60333-2: KIF1B; NbExp=3; IntAct=EBI-2850578, EBI-10975473;
CC       Q8NEZ2; O14901: KLF11; NbExp=3; IntAct=EBI-2850578, EBI-948266;
CC       Q8NEZ2; P35240: NF2; NbExp=3; IntAct=EBI-2850578, EBI-1014472;
CC       Q8NEZ2; P35240-4: NF2; NbExp=3; IntAct=EBI-2850578, EBI-1014514;
CC       Q8NEZ2; Q9BVL2: NUP58; NbExp=3; IntAct=EBI-2850578, EBI-2811583;
CC       Q8NEZ2; P60891: PRPS1; NbExp=3; IntAct=EBI-2850578, EBI-749195;
CC       Q8NEZ2; Q9Y3C5: RNF11; NbExp=3; IntAct=EBI-2850578, EBI-396669;
CC       Q8NEZ2; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-2850578, EBI-5235340;
CC       Q8NEZ2; Q13148: TARDBP; NbExp=3; IntAct=EBI-2850578, EBI-372899;
CC       Q8NEZ2; Q86WV8: TSC1; NbExp=3; IntAct=EBI-2850578, EBI-12806590;
CC       Q8NEZ2; Q99816: TSG101; NbExp=6; IntAct=EBI-2850578, EBI-346882;
CC       Q8NEZ2; O76024: WFS1; NbExp=3; IntAct=EBI-2850578, EBI-720609;
CC       Q8NEZ2-2; G5E9A7: DMWD; NbExp=3; IntAct=EBI-10270911, EBI-10976677;
CC       Q8NEZ2-2; P28799: GRN; NbExp=3; IntAct=EBI-10270911, EBI-747754;
CC       Q8NEZ2-2; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-10270911, EBI-5235340;
CC       Q8NEZ2-2; Q13148: TARDBP; NbExp=3; IntAct=EBI-10270911, EBI-372899;
CC       Q8NEZ2-2; Q8IWZ5: TRIM42; NbExp=3; IntAct=EBI-10270911, EBI-5235829;
CC       Q8NEZ2-2; Q99816: TSG101; NbExp=5; IntAct=EBI-10270911, EBI-346882;
CC   -!- SUBCELLULAR LOCATION: Late endosome membrane; Peripheral membrane
CC       protein. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NEZ2-1; Sequence=Displayed;
CC       Name=2; Synonyms=beta;
CC         IsoId=Q8NEZ2-2; Sequence=VSP_025367;
CC       Name=3;
CC         IsoId=Q8NEZ2-3; Sequence=VSP_025368, VSP_025369;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Examined tissues include heart,
CC       brain, placenta, liver, skeletal muscle, kidney and pancreas. More
CC       abundant in liver. Strongly decreased or undetected in hepatomas.
CC       {ECO:0000269|PubMed:14623289, ECO:0000269|PubMed:22717650}.
CC   -!- DISEASE: Spastic paraplegia 53, autosomal recessive (SPG53)
CC       [MIM:614898]: A form of spastic paraplegia, a neurodegenerative
CC       disorder characterized by a slow, gradual, progressive weakness and
CC       spasticity of the lower limbs. Rate of progression and the severity of
CC       symptoms are quite variable. Initial symptoms may include difficulty
CC       with balance, weakness and stiffness in the legs, muscle spasms, and
CC       dragging the toes when walking. Complicated forms are recognized by
CC       additional variable features including spastic quadriparesis, seizures,
CC       dementia, amyotrophy, extrapyramidal disturbance, cerebral or
CC       cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well
CC       as by extra neurological manifestations. SPG53 is characterized by
CC       pronounced early onset spastic paraparesis of upper and lower limbs,
CC       mild intellectual disability, kyphosis, pectus carinatum and
CC       hypertrichosis. {ECO:0000269|PubMed:22717650}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the VPS37 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH22363.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY033079; AAK54349.1; -; mRNA.
DR   EMBL; AF547097; AAQ12067.1; -; mRNA.
DR   EMBL; AK057204; BAB71381.1; -; mRNA.
DR   EMBL; AL834189; CAD38883.1; -; mRNA.
DR   EMBL; BC022363; AAH22363.1; ALT_INIT; mRNA.
DR   EMBL; BC067754; AAH67754.1; -; mRNA.
DR   CCDS; CCDS47811.1; -. [Q8NEZ2-2]
DR   CCDS; CCDS6001.1; -. [Q8NEZ2-1]
DR   RefSeq; NP_001138624.1; NM_001145152.1. [Q8NEZ2-2]
DR   RefSeq; NP_689628.2; NM_152415.2. [Q8NEZ2-1]
DR   RefSeq; XP_016868510.1; XM_017013021.1. [Q8NEZ2-1]
DR   RefSeq; XP_016868511.1; XM_017013022.1.
DR   RefSeq; XP_016868515.1; XM_017013026.1.
DR   SMR; Q8NEZ2; -.
DR   BioGRID; 126479; 23.
DR   IntAct; Q8NEZ2; 34.
DR   MINT; Q8NEZ2; -.
DR   STRING; 9606.ENSP00000318629; -.
DR   GlyGen; Q8NEZ2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8NEZ2; -.
DR   PhosphoSitePlus; Q8NEZ2; -.
DR   BioMuta; VPS37A; -.
DR   DMDM; 74715446; -.
DR   EPD; Q8NEZ2; -.
DR   jPOST; Q8NEZ2; -.
DR   MassIVE; Q8NEZ2; -.
DR   MaxQB; Q8NEZ2; -.
DR   PaxDb; Q8NEZ2; -.
DR   PeptideAtlas; Q8NEZ2; -.
DR   PRIDE; Q8NEZ2; -.
DR   ProteomicsDB; 73247; -. [Q8NEZ2-1]
DR   ProteomicsDB; 73248; -. [Q8NEZ2-2]
DR   ProteomicsDB; 73249; -. [Q8NEZ2-3]
DR   Antibodypedia; 22259; 142 antibodies.
DR   DNASU; 137492; -.
DR   Ensembl; ENST00000324849; ENSP00000318629; ENSG00000155975. [Q8NEZ2-1]
DR   Ensembl; ENST00000425020; ENSP00000412824; ENSG00000155975. [Q8NEZ2-3]
DR   Ensembl; ENST00000521829; ENSP00000429680; ENSG00000155975. [Q8NEZ2-2]
DR   GeneID; 137492; -.
DR   KEGG; hsa:137492; -.
DR   UCSC; uc003wxj.4; human. [Q8NEZ2-1]
DR   CTD; 137492; -.
DR   DisGeNET; 137492; -.
DR   GeneCards; VPS37A; -.
DR   HGNC; HGNC:24928; VPS37A.
DR   HPA; ENSG00000155975; Low tissue specificity.
DR   MalaCards; VPS37A; -.
DR   MIM; 609927; gene.
DR   MIM; 614898; phenotype.
DR   neXtProt; NX_Q8NEZ2; -.
DR   OpenTargets; ENSG00000155975; -.
DR   Orphanet; 319199; Autosomal recessive spastic paraplegia type 53.
DR   PharmGKB; PA142670615; -.
DR   VEuPathDB; HostDB:ENSG00000155975.9; -.
DR   eggNOG; KOG3270; Eukaryota.
DR   GeneTree; ENSGT00950000183012; -.
DR   HOGENOM; CLU_062319_0_0_1; -.
DR   InParanoid; Q8NEZ2; -.
DR   OMA; NGFTYKM; -.
DR   OrthoDB; 1573421at2759; -.
DR   PhylomeDB; Q8NEZ2; -.
DR   TreeFam; TF332146; -.
DR   PathwayCommons; Q8NEZ2; -.
DR   Reactome; R-HSA-162588; Budding and maturation of HIV virion.
DR   Reactome; R-HSA-174490; Membrane binding and targetting of GAG proteins.
DR   Reactome; R-HSA-917729; Endosomal Sorting Complex Required For Transport (ESCRT).
DR   Reactome; R-HSA-9610379; HCMV Late Events.
DR   Reactome; R-HSA-9615710; Late endosomal microautophagy.
DR   BioGRID-ORCS; 137492; 373 hits in 1004 CRISPR screens.
DR   ChiTaRS; VPS37A; human.
DR   GeneWiki; VPS37A; -.
DR   GenomeRNAi; 137492; -.
DR   Pharos; Q8NEZ2; Tbio.
DR   PRO; PR:Q8NEZ2; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q8NEZ2; protein.
DR   Bgee; ENSG00000155975; Expressed in corpus callosum and 211 other tissues.
DR   ExpressionAtlas; Q8NEZ2; baseline and differential.
DR   Genevisible; Q8NEZ2; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0000813; C:ESCRT I complex; IDA:UniProtKB.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0016197; P:endosomal transport; TAS:Reactome.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0016236; P:macroautophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0036258; P:multivesicular body assembly; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0006612; P:protein targeting to membrane; IBA:GO_Central.
DR   GO; GO:0006623; P:protein targeting to vacuole; IBA:GO_Central.
DR   GO; GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IMP:UniProtKB.
DR   GO; GO:0039702; P:viral budding via host ESCRT complex; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0019058; P:viral life cycle; TAS:Reactome.
DR   Gene3D; 1.10.287.660; -; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR037202; ESCRT_assembly_dom.
DR   InterPro; IPR029012; Helix_hairpin_bin_sf.
DR   InterPro; IPR009851; Mod_r.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF07200; Mod_r; 1.
DR   SUPFAM; SSF140111; SSF140111; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS51314; VPS37_C; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Endosome;
KW   Hereditary spastic paraplegia; Membrane; Neurodegeneration; Nucleus;
KW   Phosphoprotein; Protein transport; Reference proteome; Transport.
FT   CHAIN           1..397
FT                   /note="Vacuolar protein sorting-associated protein 37A"
FT                   /id="PRO_0000287198"
FT   DOMAIN          308..397
FT                   /note="VPS37 C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00646"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         42..67
FT                   /note="SIAEIQKDVEYRLPFTINNLTININI -> R (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14623289"
FT                   /id="VSP_025367"
FT   VAR_SEQ         140..185
FT                   /note="LYSNPSGMSPYASQGFPFLPPYPPQEANRSITSLSVADTVSSSTTS -> QL
FT                   EIRWHHPHCLEISLARSSNSLGFSISSSISSTRSKQEYHFFICC (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_025368"
FT   VAR_SEQ         186..397
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_025369"
FT   VARIANT         206
FT                   /note="I -> F (in dbSNP:rs17502618)"
FT                   /id="VAR_032287"
FT   VARIANT         213
FT                   /note="I -> V (in dbSNP:rs17687375)"
FT                   /id="VAR_032288"
FT   VARIANT         382
FT                   /note="K -> N (in SPG53; found in patients with complex
FT                   hereditary spastic paraparesis; hypomorphic mutation; does
FT                   not affect interaction with TSG101 and VPS28;
FT                   dbSNP:rs211694394)"
FT                   /evidence="ECO:0000269|PubMed:22717650"
FT                   /id="VAR_068424"
FT   CONFLICT        313
FT                   /note="K -> R (in Ref. 2; BAB71381)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        324
FT                   /note="S -> I (in Ref. 4; AAH67754)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   397 AA;  44314 MW;  96EBB670F04A0923 CRC64;
     MSWLFPLTKS ASSSAAGSPG GLTSLQQQKQ RLIESLRNSH SSIAEIQKDV EYRLPFTINN
     LTININILLP PQFPQEKPVI SVYPPIRHHL MDKQGVYVTS PLVNNFTMHS DLGKIIQSLL
     DEFWKNPPVL APTSTAFPYL YSNPSGMSPY ASQGFPFLPP YPPQEANRSI TSLSVADTVS
     SSTTSHTTAK PAAPSFGVLS NLPLPIPTVD ASIPTSQNGF GYKMPDVPDA FPELSELSVS
     QLTDMNEQEE VLLEQFLTLP QLKQIITDKD DLVKSIEELA RKNLLLEPSL EAKRQTVLDK
     YELLTQMKST FEKKMQRQHE LSESCSASAL QARLKVAAHE AEEESDNIAE DFLEGKMEID
     DFLSSFMEKR TICHCRRAKE EKLQQAIAMH SQFHAPL
//
